3 Generic Drug Stocks To Watch Amid Improving Industry Trends

Recent earnings across the generic drug industry point to a mixed, but generally resilient, operating environment.

Looking ahead, the industry’s near-term performance is likely to depend increasingly on execution. Companies are focused on restoring disrupted supply, maintaining a steady pace of launches, improving product mix and controlling costs.

Here, we highlight three generic drugmakers that appear well-positioned to capitalize on this evolution within the industry.

This post originally appeared at Zacks.